Mesoporous silica materials for controlled delivery based on enzymes.

Area of Science:

• Materials Science
• Nanotechnology
• Biomedical Engineering

Background:

• Mesoporous silica nanoparticles (MSNs) are widely explored for drug delivery due to their high surface area and tunable pore size.
• Controlled release systems are crucial for improving therapeutic outcomes and reducing side effects.
• Enzyme-responsive materials offer a promising avenue for targeted and triggered drug delivery.

Purpose of the Study:

• To review recent advancements in enzyme-triggered capped mesoporous silica materials for controlled delivery applications.
• To highlight the role of enzymes as triggers or integral components in the gating mechanisms of these nanomaterials.
• To discuss the potential of these systems in various therapeutic contexts.

Main Methods:

• Literature review of scientific publications focusing on enzyme-responsive mesoporous silica.
• Analysis of different capping strategies and enzyme-triggering mechanisms.
• Categorization of materials based on enzyme specificity and release kinetics.

Main Results:

• Demonstrated successful implementation of various enzymes (e.g., proteases, glycosidases) to trigger cargo release from capped MSNs.
• Illustrated diverse gating strategies involving enzyme-substrate interactions to control pore opening.
• Showcased examples of enhanced therapeutic efficacy and reduced systemic toxicity in preclinical studies.

Conclusions:

• Enzyme-triggered capped mesoporous silica materials represent a sophisticated platform for advanced controlled drug delivery.
• The precise and stimuli-responsive nature of these systems holds significant potential for future pharmaceutical development.
• Further research into biocompatibility and large-scale synthesis is warranted for clinical translation.